Procter & Gamble Hygiene and Health Care - 3QFY21 Result update by Mr. Amarjeet Maurya, Angel Broking
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Below are Views On Procter & Gamble Hygiene and Health Care - 3QFY21 Result update by Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd
For Q3FY21, Procter & Gamble Hygiene and Health Care Ltd (PGHHCL)’s net sales grew by ~16% to Rs760cr on the back of strength of our trusted product portfolio and strong retail execution. During the quarter, EBITDA stood at ~Rs129cr and EBITDA margins (at 16.0%) contracted by 204 bps due to higher other expenditures. Net Profit for the quarter was Rs98cr, up 8% vs year ago. Both the feminine care and health care business delivered strong double-digit sales growth in the quarter. Overall 3QFY21, in-results with expectation. Hence, we are positive on stock.
Above views are of the author and not of the website kindly read disclaimer
